AWende

Adam R. Wende, Ph.D.
Assistant Professor, Department of Molecular and Cellular Pathology

Areas of Focus: Mechanisms of glucose mediated regulation of cardiac mitochondrial function


Publications

Contact Information
Volker Hall G019
(205) 975-6272
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


RESEARCH DESCRIPTION

         Mechanisms of glucose mediated regulation of cardiac mitochondrial function-  Work in the laboratory has two primary goals: 1) to determine the role of metabolic substrate switching in the hearts of individuals with diabetes or heart failure, and 2) to define the role of cellular glucose delivery on post-translational regulation of mitochondrial enzyme activity and epigenetic regulation of gene expression that together may lead to the development of diabetic cardiomyopathy. The primary goal of the R00 funded research is to determine the role the protein post-translational modification O-GlcNAc has in regulating cardiac cellular function and define the role that changes in glucose levels have on long-lasting epigenetic regulation of gene expression in a process termed “glycemic memory”. By defining these molecular signatures of altered protein regulation and DNA structure/regulation we aim to provide critical knowledge to determining future therapeutic interventions for diabetic and heart failure patients

BIOGRAPHY

            Dr. Wende has spent the last decade exploring the regulation of glucose utilization in heart and muscle. After completing his undergraduate biochemistry degree at Knox College in Galesburg, IL he went on to undertake his PhD training in the Cardiology Department at Washington University in St. Louis, MO studying transcriptional regulation with Dr. Daniel P. Kelly. He then joined the University of Utah in 2006 to pursue his postdoctoral studies with Dr. E. Dale Abel examining upstream regulation by cellular signaling and the resulting changes in mitochondrial physiology. Then in August of 2013, he joined the faculty at The University of Alabama at Birmingham in the Division of Molecular and Cellular Pathology as an Assistant Professor.

His work has been funded by the American Heart Association, the JDRF, and most recently by an NIH K99/R00 award. With these training experiences he has expanded his research through use of transgenic and diabetes mouse models to identify molecular and genetic mechanisms of glucose-mediated control of mitochondrial function. His outside interests include time with his wife and two young daughters and running marathons.